# Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication

> **NCT02541864** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 330 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Bismuth quadruple therapy
- **DRUG:** Hybrid therapy

## Key facts

- **NCT ID:** NCT02541864
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02541864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02541864, "Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02541864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*